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The human growth hormone (hGH) minigene is
frequently used in the derivation of transgenic mouse
lines to enhance transgene expression. Although this
minigene is present in the transgenes as a second-
cistron, and thus not thought to be expressed, we
found that three commonly used lines, Pdx1-CreLate,
RIP-Cre, and MIP-GFP, each expressed significant
amounts of hGH in pancreatic islets. Locally secreted
hGH binds to prolactin receptors on b cells, activates
STAT5 signaling, and induces pregnancy-like
changes in gene expression, thereby augmenting
pancreatic b cell mass and insulin content. In addi-
tion, islets of Pdx1-CreLate mice have lower GLUT2
expression and reduced glucose-induced insulin
release and are protected against the b cell toxin
streptozotocin. These findings may be important
when interpreting results obtained when these and
other hGH minigene-containing transgenic mice are
used.
INTRODUCTION
Conditional inactivation of genes in mice by specific DNA
recombination in target tissues was developed in the early 90s
(Orban et al., 1992). By then, it was already known that intronic
sequences and a polyadenylation signal are essential to achieve
efficient expression of the transgene (Brinster et al., 1988). The
entire human growth hormone (hGH) coding region, including
introns and polyadenylation signal (also called hGH minigene),
was oftentimes inserted downstream of coding regions, suchCell Mas that of Cre recombinase, to generate transgenic mouse
models (Orban et al., 1992), some of which are in wide use
today.
Prolactin (PRL), placental lactogen (PL), and GH are homol-
ogous proteins that display overlapping structure (Goffin et al.,
1996) and biological activities (Soares, 2004). The lactogens
PRL and PL have a profound effect on the pancreatic islet
phenotype of pregnant females (Parsons et al., 1992; Soren-
son et al., 1987). During pregnancy, insulin resistance is
induced in the mother, which facilitates nutrient flow toward
the fetus (Freemark, 2006). To compensate for this increased
metabolic demand and to prevent hyperglycemia, maternal
pancreatic b cells undergo several structural and functional
changes. These changes have been under investigation for
several decades and involve multiple b cell parameters, such
as increased glucose-stimulated insulin secretion (GSIS)
(Green and Taylor, 1972), enhanced b cell proliferation (Van
Assche, 1974), accelerated proinsulin biosynthesis (Bone
and Taylor, 1976), a higher rate of glucose oxidation and
glucose utilization (Green et al., 1978; Weinhaus et al.,
1996), and increased gap-junctional coupling of b cells (Sher-
idan et al., 1988). The importance of lactogens in this pheno-
typic switch has been demonstrated in mouse models in
which b cell-specific overexpression of PL leads to enhanced
insulin secretion and increased b cell mass (Fleenor et al.,
2000; Vasavada et al., 2000). These signals are mediated by
prolactin receptors (PRLR), as was demonstrated in Prlr+/
mice (Huang et al., 2009). Growth hormones of primates, but
not of other vertebrates, are also able to activate PRLR, a
property that is maintained in several heterologous systems
(Goffin et al., 1996). Accordingly, it was shown that hGH can
mimic the effects of lactogens on mouse and rat b cells (Par-
sons et al., 1995).
To define the molecular basis of lactogen signaling during
pregnancy, we and others recently explored the changesetabolism 20, 979–990, December 2, 2014 ª2014 Elsevier Inc. 979
Figure 1. Increased b Cell Mass and Insu-
lin Content in Nonpregnant Pdx1-CreLate
Mice
(A and B) Blood glucose levels in random-fed (A)
and fasted (B) Pdx1-CreLate versus control mice.
Data are represented as mean ± SEM, n = 7 mice
per genotype, **p < 0.01.
(C) Insulin tolerance test (ITT) on 10-week-
old Pdx1-CreLate versus control mice. Values
are presented as a percentage compared to
the starting glucose level. Data are repre-
sented as mean ± SEM, n = 7–8 mice per
genotype.
(D) Quantification of b cell mass in 24-week-old
Pdx1-CreLate versus control mice, performed as
described in the Experimental Procedures. Data
are represented as mean ± SEM, n = 4 mice per
genotype, **p < 0.01.
(E) Pancreatic insulin content in 24-week-old
Pdx1-CreLate versus control mice. Data are rep-
resented as mean ± SEM, n = 9–10 mice per
genotype, **p < 0.01.
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hGH-Induced Phenotypic Switch in Control Isletsthat occur in the gene expression using genome-wide mRNA
expression analysis (Kim et al., 2010; Rieck et al., 2009;
Schraenen et al., 2010a, 2010b). The largest cluster of
upregulated genes during pregnancy regulates b cell mass
(Schraenen et al., 2010a). In addition, a strong induction of
the serotonin biosynthetic pathway was found in a subset of
b cells (Schraenen et al., 2010b). Genes encoding tryptophan
hydroxylase-1 (TPH1) and tryptophan hydroxylase-2 (TPH2),
catalyzing the rate-limiting step of serotonin biosynthesis,
were found to be vastly upregulated (Kim et al., 2010; Schrae-
nen et al., 2010b), resulting in an increase in islet serotonin
content greater than 100-fold. The responsible mechanism
involved PRLR and activation of its canonical Janus kinase
2 (JAK2)/signal transducer and activator of transcription 5
(STAT5) signaling pathway (Schraenen et al., 2010b). An auto-
crine/paracrine role for serotonin has been suggested in acti-
vating b cell proliferation via serotonin receptor 2B (Kim et al.,
2010).
Here we describe unexpected functional consequences re-
sulting from the placement of hGH minigene in the transgenic
constructs. The principal mouse strain used for these studies
was the Tg(Pdx1-cre)1Herr mouse strain, also known as the
Pdx1-CreLate model (Herrera, 2000). This transgenic line con-
tains a 4.5 kb fragment of the Pdx1 promoter inserted upstream
of the Cre recombinase-coding region and an hGH minigene
in order to achieve efficient transgene expression. We studied
the expression of hGH at the mRNA and protein level
and the consequences for islets from Pdx1-CreLate mice, such
as changes in b cell mass and insulin secretion. In addition,
we examined hGH expression and serotonin biosynthesis
in two other lines that are frequently used for pancreatic980 Cell Metabolism 20, 979–990, December 2, 2014 ª2014 Elsevier Inc.islet research: the C57BL/6-Tg(Ins2-cre)
25Mgn/J line (Postic et al., 1999), which
is frequently used to generate b cell
conditional gene knockouts, and the
B6.Cg-Tg(Ins1-EGFP)1Hara/J line, which
is often used to visualize and/or purifypancreatic b cells (Hara et al., 2003), from now on referred to
as RIP-Cre and MIP-GFP, respectively.
RESULTS
Pancreata fromPdx1-CreLateMiceHave IncreasedbCell
Mass and Insulin Content
While working with the Pdx1-CreLate driver line to generate a new
b cell-specific knockout strain, we found that circulating blood
glucose, in both the random-fed (Figure 1A) and fasted state
(Figure 1B), was lower in the Pdx1-CreLatemice than in littermate
controls. This difference could not be explained by enhanced in-
sulin sensitivity of Pdx1-CreLate mice (Figure 1C). Instead, we
observed an increase in pancreatic b cell mass (Figure 1D),
which was accompanied by a nearly doubled pancreatic insulin
content (Figure 1E, Pdx1-CreLate 390 ± 19 mg/g versus WT 204 ±
52 mg/g, n = 9–10/genotype, p = 0.006).
Paracrine/Autocrine PRLR Activation by hGH in Islets
from Nonpregnant Pdx1-CreLate Mice
In the original description of the Pdx1-CreLatemousemodel (Her-
rera, 2000), the complete coding hGH gene sequence, including
exons, introns, and its polyadenylation signal, is present down-
stream of the Pdx1 promoter and Cre recombinase (Figure 2A).
Results from Figures 2B–2F demonstrate that the hGHminigene
is specifically and highly expressed in mouse b cells of the Pdx1-
CreLate strain. We quantified hGH expression at both the mRNA
level (Figure 2B) and protein level (Figures 2C–2E). We found sig-
nificant hGH expression only in pancreatic islets, but not in the
other tissues (Figure 2B), including the exocrine part of the
pancreas (Figure 2D). Western blots (Figure 2C) indicated that
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hGH-Induced Phenotypic Switch in Control Isletsthe mature hormone of the expected molecular weight (22 kDa)
was produced in Pdx1-CreLate islets. Quantification of hGH in ex-
tracts from isolated islets and in conditioned medium (Figure 2F)
shows that approximately 4%of cellular hGH content is released
per hour from 20 mM glucose-stimulated Pdx1-CreLate islets.
Figure 2G supports the idea that locally secreted hGH has func-
tional effects on pancreatic islet in vivo. Indeed, a significant
increase (3.7-fold, n = 3, p = 0.005) in STAT5 phosphorylation
was detected in freshly isolated Pdx1-CreLate islets compared
to control islets (Figure 2G). Because hGH can bind to GH recep-
tors (GHR) and to PRLR (Goffin et al., 1996), and since both re-
ceptors are strongly expressed in rodent b cells (Brelje et al.,
2002; Møldrup et al., 1993), we next investigated the mechanism
by which hGH causes phenotypic changes in b cells. We first
usedMIN6 cells as a surrogatemodel formouse b cells (Miyazaki
et al., 1990) and quantified Tph1 as a marker for lactogen-medi-
ated PRLR activation, taking ovine PL (oPL) as a positive control
(Schraenen et al., 2010b). As is shown in Figure 2H, both hGH
and oPL were very potent ligands in this assay, as a significant
induction of Tph1 mRNA was already observed with 25 ng/ml
(1 nM). In comparison, the minimal effective concentration of
mouse (m)GH, which only binds to GHR, was 500 ng/ml, indi-
cating that synthetic hGH was at least 20-fold more potent.
Similar results were obtained with primary islets: a significant in-
duction of Tph1 mRNA was found in islet monolayers treated
with 500 ng/ml oPL or hGH, but not after treatment with mGH
(Figure 2I). To confirm that hGH stimulation of Tph1 expression
is mediated by PRLR signaling, MIN6 cells stimulated or not
with 25 ng/ml hGH were cotreated with increasing concentra-
tions of the synthetic PRLR antagonist D1-9-G129R-hPRL (Ber-
nichtein et al., 2003). A concentration-dependent antagonism
was observed (Figure 2I). Together, our data indicate that lacto-
gen-like increment of pancreatic b cell mass and insulin content
in Pdx1-CreLate mice is initiated by local hGH release and medi-
ated by activation of PRLR.
Activation of a Pregnancy-Related Phenotypic Switch in
Islets from Pdx1-CreLate Mice
The autocrine/paracrine PRLR stimulation by local release of
hGH in pancreatic islets not only enhanced the b cell mass but
also upregulated more than 100 genes that are also upregulated
in islets from C57BL/6J pregnant mice (Figure 3A). This was
measured by comparison of the global islet gene expression pro-
file in 12-week-old Pdx1-CreLate mice and control nonpregnant
littermates as well as islet from C57BL/6J pregnant mice not
carrying the Pdx1-CreLate insertion. More than 50% (121/218)
of the upregulated genes in nonpregnant Pdx1-CreLate islets
were also upregulated during pregnancy (Figure 3A). Overlap
was complete for a pregnancy gene expression signature, con-
sisting of 12 known genes described previously to be highly up-
regulated during pregnancy (fold increaseR 3 and p < 0.001 at
pregnancy day 12.5) (Figure S1, available online). For this
strongly induced pregnancy gene expression signature, we
confirmed by quantitative RT-PCR (qRT-PCR) analysis that the
mRNA signal in Pdx1-CreLate islets was significantly higher
than in control islets (Figure 3B). The two transcripts that encode
the nonallelic paralogs of tryptophan hydroxylase, Tph1 and
Tph2, were highly induced in Pdx1-CreLate islets: 346.3 ± 69.4-
fold (p = 0.004) and 14.3 ± 3.2-fold (p = 0.011), respectively. ToCell Massess the importance of the PRLR in the pregnancy switch
in vivo, expression of the 12 genes in the gene expression signa-
ture was quantified in islets from Pdx1-CreLate;PRLR/ mice
versus Pdx1-CreLate littermates by qRT-PCR. A significant
reduction in gene expression was observed for most of the 12
genes in the Pdx1-CreLate;PRLR/ mouse model as compared
to Pdx1-CreLate controls (Figure 3C), again stressing the crucial
role of the PRLR in the pregnancy switch.
Because DOPA decarboxylase, the second enzyme needed
for serotonin biosynthesis from tryptophan, is constitutively
and highly expressed in mouse pancreatic islets, the strong up-
regulation of the tryptophan hydroxylase step indicates that is-
lets of Pdx1-CreLate mice are competent to synthesize serotonin
under nonpregnant conditions. This is in contrast to control mice,
which only produce serotonin during pregnancy. Therefore, we
quantified islet serotonin content of control and Pdx1-CreLate
mice under nonpregnant conditions and observed a striking dif-
ference (Figure 3D). This difference between mouse genotypes
contrasted with islet gamma-amino butyric acid (GABA) (Fig-
ure 3E), a neurotransmitter that is constitutively produced by
decarboxylation of glutamate in rodent and human b cells (Sor-
enson et al., 1991). Consequently, the islet serotonin/GABA
molar ratio increased by at least one order of magnitude in islet
extracts from the nonpregnant Pdx1-CreLate strain (Figure 3F).
To analyze the serotonin production at the cellular level in
nonpregnant Pdx1-CreLate mice, we performed immunostaining
on pancreatic islet sections. A heterogeneous pattern of seroto-
nin immunoreactivity was found in islet b cells of nonpregnant
Pdx1-CreLate mice (Figure 3G), similar to the production
observed in wild-type C57BL/6J mice during pregnancy
(Schraenen et al., 2010b). No serotonin immunoreactivity was
detected in nonpregnant control mice. Together, these data
show that the normal serotonin biosynthetic pathway, observed
in a subpopulation of b cells in the pancreas of pregnant mice, is
induced independently of pregnancy in islets from Pdx1-CreLate
mice.
Impaired Glucose Tolerance and Reduced Islet GLUT2
Expression in Pdx1-CreLate Mice
Overlap between genes that are downregulated in islets from
pregnant wild-type C57BL/6J mice versus nonpregnant Pdx1-
CreLate mice was much weaker (Figure 3A). One example was
the mRNA encoding the glucose transporter GLUT2, which
was repressed in Pdx1-CreLate islets (Figure 4A), but not in islets
from pregnant mice. GLUT2 acts as a glucose sensor protein in
rodent pancreatic b cells and is essential for normal glucose ho-
meostasis inmice (Guillam et al., 1997; Thorens et al., 1988). This
reduction in Glut2 mRNA expression correlated with a strong
reduction in immunoreactive protein on islet b cell membranes
(Figure 4B) but contrasted with that of other genes involved in
GSIS, which remained at the control level in islets isolated from
Pdx1-CreLatemice (Figure S2A). The reduction of GLUT2 expres-
sion also coincided with a partial loss of GSIS with either 20 mM
glucose or 20 mM glucose plus the phosphodiesterase inhibitor
3-isobutyl-1-methylxanthine (IBMX) as well as higher basal
release (Figure 4C). This abnormality was associated with a
slightly decreased glucose tolerance (Figure 4D) and lower circu-
lating insulin levels (Figure 4E) after 2.5 mg/g body weight (BW)
intraperitoneal (i.p.) glucose injection. Glucose intolerance wasetabolism 20, 979–990, December 2, 2014 ª2014 Elsevier Inc. 981
Figure 2. Pregnancy-Related Phenotypic Changes Are Caused by Local Production and Secretion of hGH in Islets from Nonpregnant
Pdx1-CreLate Mice
(A) Schematic representation of the Pdx1-Cre construct used to generate the Pdx1-CreLate mouse model. A 4.5 kb Pdx1 promoter fragment was inserted up-
stream of the Cre transgene. The hGHminigene, containing introns, exons, and polyadenylation signal, is located directly downstream of the Cre fragment and
indicated in red. This figure was based on the materials and methods from Herrera (2000).
(B) qRT-PCR analysis of hGHmRNA in different tissues, including isolated islets from control and nonpregnant Pdx1-CreLate mice. Data were quantified as delta
Ct values (relative to Gapdh). Data are represented as mean ± SEM, n = 3–6 per condition, ***p < 0.001.
(C) Western blot analysis of hGH expression in islets of control and nonpregnant Pdx1-CreLate mice. GAPDH was used as a loading control.
(D) Immunoreactive hGH in pancreatic sections from control and nonpregnant Pdx1-CreLate mice. The hGH signal is most intense in pancreatic islets and not
uniformly distributed over their different islet cells. Scale bar, 100 mm.
(E and F) Quantification of hGH content (E) and release (F) (measured as the percentage of cellular content per hour) in islets isolated from Pdx1-CreLatemice. For
the release experiments, isolated islets were incubated with 20 mM D-glucose for 1 hr. Data are represented as mean ± SEM, n = 3 per condition, **p < 0.01.
(G) Representative immunoblot of islet phospho-STAT5 (P-STAT5) and total STAT5 protein in islets from control and nonpregnantPdx1-CreLatemice. GAPDHwas
used as a loading control. Mean density ratios of P-STAT5/total STAT5 were increased 3.72 ± 0.38-fold in Pdx1-CreLate islets compared to controls. Data are
represented as mean ± SEM, n = 3 per condition, p = 0.005.
(legend continued on next page)
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hGH-Induced Phenotypic Switch in Control Isletsevenmore pronounced in olderPdx1-CreLatemice (20weeks old)
(Figure S2B). However, glycemia turned back to starting levels at
the same time point as that for control mice. Together, these data
indicate that in addition to some pregnancy-related phenotypic
changes, local release of hGH induces other changes in pancre-
atic islets, as exemplified by reduced GLUT2 and partial loss of
GSIS in Pdx1-CreLate islets.
Pdx1-CreLate Mice Are Protected against the
Diabetogenic Toxin Streptozotocin
The GLUT2 transporter on the b cell surface is also responsible
for the uptake of the b cell toxin streptozotocin (STZ) (Schnedl
et al., 1994). Consequently, in control mice, which have very
high levels of GLUT2 expression on b cells, STZ can induce an
acute b cell necrosis after single injection of a high dose or chron-
ically after multiple low-dose injections (Lenzen, 2008). As the
Glut2 gene expression is reduced in Pdx1-CreLate islets, the ef-
fect of STZmight be diminished. Moreover, PRL-induced activa-
tion of the JAK2/STAT5 pathway was reported to protect mice
against multiple low doses of STZ (Holstad and Sandler, 1999;
Jackerott et al., 2006). The effect of these two protective
changes in islets of Pdx1-CreLate mice on blood glucose levels
was tested in the multiple low-dose STZ model (50 mg/kg BW
for 5 consecutive days and 1 month follow up of blood glucose
levels; Figure 4F) as well as in the single high-dose STZ model
(150mg/kg BW and 5 days of follow up; Figure 4G). Pdx1-CreLate
mice remained normoglycemic during the whole follow-up
period in both models, whereas all control animals developed
diabetes. However, the protection of Pdx1-CreLate mice against
a single high-dose STZ injection was completely lost whenPdx1-
CreLate mice were crossed to Prlr/, further emphasizing the
involvement of the PRLR in the hGH-induced phenotypic
changes observed in Pdx1-CreLate mice (Figure 4H).
hGHandSerotonin Production AlsoOccurs in Islets from
RIP-Cre and MIP-GFP Mice
Since many transgenic mouse models, in addition to the Pdx1-
CreLate animals, incorporated a hGH minigene in their design
(see Table 1), we also examined whether hGH protein is pro-
duced in MIP-GFP and RIP-Cre islets, two transgenic lines
that are commonly used in studies of b cell biology and cellular
mechanisms of diabetes. While expression of the hGH mRNA
was expected given the placement of the gene sequences in
the transgene construct (Figure 5A), hGH protein immunoreac-
tivity was also observed (Figures 5B and S3). Furthermore, we
found evidence for a pregnancy-related phenotypic switch as
illustrated by a strong induction of Tph1 mRNA (Figure 5A)
and immunoreactive serotonin in islets from MIP-GFP and
RIP-Cre islets (Figure 5C and quantified in Figure S4). There-
fore, the presence and functional activity of hGH protein is(H and I) Induction of Tph1 expression in MIN6 cells (H) and primary islet monola
of oPL, mGH, or hGH, and islet monolayers with vehicle (control) or 500 ng/ml
was used as a reference gene. Data were calculated via the Pfaffl method, and
mean ± SEM, n = 3–5 independent measurements per condition; *p < 0.05, **p <
(J) Inhibition of hGH-induced Tph1 expression in MIN6 cells by a specific PRLR inh
antagonistD1-9-G129R-hPRLwere stimulated with 0 or 25 ng/ml hGH; Tph1mRN
used as a reference gene. Data were calculated via the Pfaffl method, and the av
n = 3 per condition; *p < 0.05, **p < 0.01.
Cell Mnot limited to Pdx1-CreLate mice, but also occurs in these two
other lines. Similar to what was observed in the Pdx1-CreLate
mice, 9-week-old MIP-GFP mice had lower blood glucose
levels after an overnight fast (Figure S5A) and lower plasma in-
sulin levels 30 min after the start of the glucose tolerance test
(Figures S5B and S5C), whereas insulin sensitivity was normal
(Figure S5D).
DISCUSSION
The Cre/LoxP system is a powerful tool to conditionally inacti-
vate or overexpress genes in transgenic animals with a number
of specific advantages over whole-body knockouts. However,
there have been many reports describing specific limitations of
some Cre driver strains. These include variegated Cre expres-
sion in target organs (Gannon et al., 2000; Ryding et al., 2001),
ectopic expression in undesired tissues (Delacour et al., 2004;
Song et al., 2010; Wicksteed et al., 2010), and unwanted effects
related to the integration site (Cartwright and Wang, 2009). For
central nervous system and pancreas-specific Cre driver lines,
these limitations and their likely causes have been reviewed
recently (Harno et al., 2013; Magnuson and Osipovich, 2013).
In particular for the RIP-Cre mouse model (Postic et al., 1999),
a multicenter study showed glucose intolerance in these mice
in the absence of genes targeted by loxP sites (Lee et al.,
2006).Moreover, youngerRIP-Cremice exhibited b cell hypopla-
sia, whereas older mice showed b cell hyperplasia (Pomplun
et al., 2007).
In the present study, we describe amechanismwhereby inclu-
sion of an hGH minigene as a component of the transgene
construct can impair b cell function. Since the hGH minigene is
the second cistron in the transgene-encoded mRNA, it was
believed for a long time that it was not expressed. Our studies
provide compelling data otherwise. Expression of hGH may
have a profound influence on the interpretation of certain types
of experiments, especially those pertaining to the control of
pancreatic b cell mass and the regulation of insulin secretion,
both of which are very active fields of diabetes research.
In islets from Pdx1-CreLate, the MIP-GFP, and the RIP-Cre
mouse models, we observed expression of hGH from the hGH
minigene sequences placed downstream of theCre orGFP cod-
ing regions (Brinster et al., 1988). As a result, hGH of the ex-
pected molecular weight (22 kDa) is synthesized and secreted
from islets of these mice, causing Cre- or GFP-independent ef-
fects by autocrine/paracrine stimulation of b cells. An insertional
effect has been postulated before (Lee et al., 2006; Pomplun
et al., 2007) but is unlikely since we observe Tph1 expression
and serotonin immunoreactivity in two other frequently used
mouse lines (RIP-Cre andMIP-GFP). Figure 6 proposes a model
in which locally secreted hGH acts as a lactogen by activatingyers (I) by hGH and oPL. Cells were treated with the indicated concentrations
oPL, mGH, or hGH. Expression of Tph1 was quantified by qRT-PCR. Polr2a
the ratio of the control sample was normalized to 1. Data are represented as
0.01, ***p < 0.001.
ibitor. MIN6 cells preincubated (30 min) with different concentrations of PRLR-
A expressionwas used as readout for the pregnancy signature, andPolr2awas
erage ratio of 0 ng/ml hGH was set to 1. Data are represented as mean ± SEM,
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Figure 3. Pregnancy-Related Phenotypic Switch in Islets Isolated from Nonpregnant Pdx1-CreLate Mice
(A) Microarray analysis of islet mRNA expression. A substantial overlap of >100 differentially expressed genes (p < 0.001 and fold change ofR1.5) was found
when comparing pregnant versus nonpregnant mice on the one hand (left) and nonpregnant Pdx1-CreLate mice versus nonpregnant control mice on the other
hand (right). This overlap contains almost 10-fold more upregulated than downregulated genes.
(B) qRT-PCR analysis of the pregnancy gene signature in nonpregnant Pdx1-CreLate versus control mice. For each of the top 12 upregulated genes during
pregnancy at P12.5, we observed significant upregulation in islets from nonpregnant Pdx1-CreLate mice. Polr2a was used as a reference gene. Data were
calculated via the Pfaffl method, and the average ratio of each gene was set to 1 for the control mice. Two strongly induced genes in islets from Pdx1-CreLatemice
encode the two isoforms of tryptophan hydroxylase (TPH1 and TPH2). Data are represented asmean ± SEM, n = 4–6 per group; *p < 0.05, **p < 0.01, ***p < 0.001.
(C) qRT-PCR analysis on all 12 genes from the pregnancy gene expression signature, in islets from Pdx1-CreLate;PRLR/mice versus Pdx1-CreLate littermates,
n = 3 mice per genotype. Data are represented as mean ± SEM, n = 3 per group, *p < 0.05, **p < 0.01, ***p < 0.001.
(D–F) Quantification of serotonin and GABA in islets isolated from nonpregnant control and nonpregnant Pdx1-CreLate mice. (D) Basal islet serotonin levels are
near the detection limit of the assay in control mice and dramatically upregulated in nonpregnant Pdx1-CreLatemice. (E) In contrast, GABA is as abundant in islets
of control as in islets of nonpregnant Pdx1-CreLate mice. (F) Consequently, the molar serotonin/GABA ratio is about 100-fold higher in islets from Pdx1-CreLate
mice compared to control islets. Data are represented as mean ± SEM, n = 5–6 per group; *p < 0.05, **p < 0.01, ***p < 0.001.
(G) Heterogeneous serotonin immunoreactivity in islets from nonpregnant Pdx1-CreLatemice. No serotonin immunoreactivity is detected in control mice, while in
nonpregnant Pdx1-CreLate mice serotonin is only present in islet b cells with marked differences between neighboring b cells. Data are representative sections
from pancreata analyzed from five nonpregnant control mice and four nonpregnant Pdx1-CreLate mice (scale bar, 20 mm). See also Figure S1 and Table S1.
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Figure 4. Reduced Islet GLUT2 Expression, Loss of GSIS, and Protection against STZ in Pdx1-CreLate Mice
(A) Glut2 mRNA signal in control versus Pdx1-CreLate islets. Gapdh was used as a reference gene. Data are represented as mean ± SEM, n = 3–4 mice per
genotype, ***p < 0.001.
(B) Representative immunofluorescence staining for insulin (green signal), GLUT2 (red signal), andmerge on pancreatic sections from control versusPdx1-CreLate
mice. Overall, the GLUT2 signal is much weaker in Pdx1-CreLate islets compared to controls. Scale bar, 20 mm.
(C) Ex vivo insulin secretion assay. Islets from Pdx1-CreLate and control mice were isolated and incubated for 1 hr with 5 mM (G5), 20 mM (G20), or 20 mM
D-glucose with the phosphodiesterase inhibitor IBMX (G20 + IBMX) Insulin release was quantified as the percentage of insulin secreted compared to islet insulin
content. Data are represented as mean ± SEM, n = 6 mice per genotype; *p < 0.05, **p < 0.01.
(D) Intraperitoneal glucose tolerance test (IPGTT) on 10-week-old Pdx1-CreLate versus control mice, n = 5 per genotype. Overnight fasted mice were injected
i.p. with 2.5 mg/g BW D-glucose and blood glucose levels were measured at the indicated time points. Data are represented as mean ± SEM, n = 5 mice per
genotype; ***p < 0.001, repeated measures ANOVA.
(E) Circulating plasma insulin levels in blood samples obtained at the indicated time points from IPGTT. Data are represented as mean ± SEM, n = 5 mice per
genotype; *p < 0.05, ***p < 0.001, repeated measures ANOVA.
(F) Multiple low-dose (MLD) treatment of the diabetogenic agent streptozotocin (STZ) in Pdx1-CreLate versus control mice. Mice aged 12 weeks were injected
i.p. with 50 mg STZ/kg BW for 5 consecutive days, and random-fed blood glucose levels were measured at the indicated time points. Data are represented as
mean ± SEM, n = 5 mice per genotype; *p < 0.05, **p < 0.01, ***p < 0.001, repeated measures ANOVA.
(G) Single high dose of STZ in Pdx1-CreLate versus control mice. Mice were injected i.p. with 150 mg STZ/kg BW, and fed blood glucose levels were measured.
Data are represented as mean ± SEM, n = 5–6 mice per genotype; ***p < 0.001, repeated measures ANOVA.
(H) Single high dose (150 mg/kg BW) of STZ in Prlr/ versus Pdx1-CreLate; Prlr/ mice. Data are represented as mean ± SEM, n = 3–4 mice per genotype;
**p < 0.01, repeated measures ANOVA. See also Figure S2.
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Table 1. b Cell-Specific Transgenic Mice Generated Based on a
Similar Strategy, Namely Using the hGH Minigene as Transgene
Enhancer
Common Strain Name Reference
Ins-rtTA/TetO-RXRbDC2 Miyazaki et al., 2010
MIP-CFP Hara et al., 2006
MIP-Cy3.3er Hara et al., 2004
MIP-GFP Hara et al., 2003
MIP-HIMP1 Zhang et al., 2012
MIP-hProCpepGFP Hodish et al., 2010
MIP-Luc Park et al., 2005
MIP-Phogrin-pHluorin-mCherryhip-rxr Lu et al., 2009
MIP-RFP Hara et al., 2006
MIP-sr39tk McGirr et al., 2011
Pdx1-CreLate Herrera, 2000
Pdx1-eGFP Sylvestersen et al., 2011
RIP-Cx32 Charollais et al., 2000
RIP-Cx43 Klee et al., 2011
RIP-HGF Garcia-Ocan˜a et al., 2000
RIP-PL Vasavada et al., 2000
RIP-PTHrP Vasavada et al., 1996
RIP-TGFb1 Sanvito et al., 1995
RIP-VegfA165 Gannon et al., 2002
RIP1-Podo Wicki et al., 2006
RIP1-VEGFD Kopfstein et al., 2007
RIP2-Cre Postic et al., 1999
This table includes the names of the strains that were identified and the
references of the first report.
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hGH-Induced Phenotypic Switch in Control Isletsabundantly expressed PRLR on mouse b cells and initiating the
JAK2/STAT5 signaling pathway. A first group of effects is there-
fore pregnancy like and includes induction of serotonin biosyn-
thesis and a doubling of b cell mass and pancreatic insulin con-
tent. The most important of pregnancy-unrelated effects is
a partial loss of GSIS, decreasing glucose tolerance. This loss
of function could be partially caused by downregulation of
GLUT2, a transporter responsible for the rapid equilibration be-
tween extra- and intracellular glucose concentration and thus
the first step of glucose sensing in rodent islets (Guillam et al.,
1997). This is in contrast with the pregnancy state, as b cell
Glut2 levels have been reported to increase as part of the adap-
tive maternal response (Weinhaus et al., 1996). GLUT2 is also
needed for rapid uptake of the b cell toxins STZ (Schnedl et al.,
1994) and alloxan (De Vos et al., 1995), so it seems reasonable
to attribute the protection of Pdx1-CreLate islets against STZ-
induced diabetes to reduced toxin uptake rates caused by fewer
GLUT2 channels (Figure 5). In addition, enhanced b cell mass
and greater potential to regenerate new b cells may also be
involved.
As the hGHminigene is frequently used to enhance expression
of transgenes, we did a literature search for mouse lines gener-
ated using the same genetic strategy (Table 1). At the time of
preparation of this manuscript, we listed a total of 22 mouse
models. Due to the lack of information available for several other
b cell-specific mouse strains, our table may be an underestima-986 Cell Metabolism 20, 979–990, December 2, 2014 ª2014 Elseviertion of the total amount of models involved. In some of the
models listed in Table 1, expression of the hGH minigene was
mentioned, at the level of either mRNA (Miyazaki et al., 2010;
Postic et al., 1999; Sanvito et al., 1995) or immunoreactive pro-
tein (Klee et al., 2011). In none of them, however, was the poten-
tial influence on pancreatic islet morphology, b cell function, or
glucose homeostasis considered.
The investigation of cellular and physiological mechanisms
that regulate b cell mass and b cell function is currently a very
active area of diabetes research that makes extensive use of
genetically altered mice. Moreover, there is already a large
body of experimental work that has made use of mice containing
hGHminigene. Our current observations therefore seem to have
potential implications on the interpretation of a large body of
published data, in particular with respect to changes in func-
tional b cell mass, insulin secretion, and protection against the
diabetogenic effect of STZ.
EXPERIMENTAL PROCEDURES
Mice
Pdx1-CreLate transgenic mice (Herrera, 2000) (Dr. Herrera, University of
Geneva, Switzerland) were crossed with C57BL/6J (Janvier) for at least eight
generations. PRLR knockout mice (designated Prlr/) on a 129Sv back-
ground were described previously (Freemark et al., 2002). Pdx1-Crelate fe-
males were bred with Prlr+/ males to generate Pdx1-CreLate; Prlr+/ mice,
which were subsequently crossed with Prlr+/ to obtain Pdx1-CreLate; Prlr/
mice. Institutional guidelines for animal welfare and experimental conduct
were followed. All experiments with laboratory animals were approved by
the committee for animal welfare at the KU Leuven. RIP-Cre mice (Postic
et al., 1999) and MIP-GFP mice (Hara et al., 2003) were maintained on
C57Bl and CD1 backgrounds, respectively. All animal procedures and hus-
bandry were approved by the Vanderbilt University Institutional Animal Care
and Use Committee.
Cell Cultures
MIN6 cells were incubated in Dulbecco’s modified Eagle’s medium (DMEM;
25 mmol/l glucose, 2% fetal calf serum [FCS], 4 mmol/l glutamax) (Invitro-
gen, Gibco) with hGH (Calbiochem), mGH, or oPL (Prospec). For the exper-
iments with the PRLR antagonist D1-9-G129R-hPRL MIN6 cells were
preincubated for 30 min with the antagonist. Thereafter, recombinant
hGH (from Vincent Goffin) was added to the medium. RNA was extracted
24 hr later.
Islet Isolation
Pancreatic islets were isolated after infusion and digestion of the pancreata by
collagenase P (Roche) as described previously (Lemaire et al., 2009).
Islet Monolayers
Islet monolayers were performed as described previously (Schraenen et al.,
2010b). Isolated islets were cultured for 7 days in RPMI medium (10% [v/v] de-
complemented FCS, 100 U/ml penicillin, 100 mg/ml streptomycin, 4 mmol/l
glutamax, 10 mM HEPES [pH 7.4]) to form monolayers. On day 7, they were
stimulated with 0 or 500 ng/ml oPL, mGH, or hGH.
Microarray Expression Analysis
Microarray analysis was performed on RNA of isolated islets using MoGen-
e_1.0_ST arrays (Affymetrix). For RNA extraction, see Supplemental Experi-
mental Procedures. Total islet RNA (100 ng) was used to hybridize the arrays
according to manufacturer’s manual 701880Rev4 as described previously
(Lemaire et al., 2009). Samples were analyzed pairwise, using p < 0.001 and
fold changeR 1.5 as selection criteria. A list of up- and downregulated genes
in islets isolated from Pdx1-CreLate transgenic mice versus control mice is pro-
vided as an excel table (see Table S1), and genes related to pregnancy are
marked.Inc.
Figure 5. Growth Hormone and Tph1 Expression and Islet Serotonin Immunoreactivity in Pancreatic Islets from Two Other Commonly Used
Mouse Driver Strains, MIP-GFP and RIP-Cre
(A) hGH and Tph1 mRNA signal in isolated islets fromMIP-GFP and RIP-Cremice, quantified as delta Ct values relative to a housekeeping mRNA signal (Hprt).
Data are represented as mean ± SEM, n = 3–6 mice per genotype, ***p < 0.001.
(B) Western blot analysis of hGH expression in islets fromMIP-GFP, RIP-Cre, and C57Bl6 control mice. Predicted hGH weight = 22 kDa. GAPDH was used as a
loading control. See also Figure S3.
(C) Representative immunofluorescence micrographs show serotonin immunoreactivity in islets from MIP-GFP and RIP-Cre mice, whereas no signal was
observed in respective littermate controls. Scale bar, 50 mm. See also Figures S4 and S5.
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Following cDNA synthesis using a reverse transcriptase kit (RevertAid H
Minus; Fermentas), qRT-PCR (Absolute QPCR mix; Abgene, Thermo Fisher
Scientific) was performed on a Rotorgene (Corbett Research). For primers
and probes, see Supplemental Experimental Procedures. For Tph2, a Taqman
gene expression assay (Mm00557717_m1; Applied Biosystems) was used.
When a probe was used, data were analyzed according to the Pfaffl method;
without a probe, delta Ct was used.
Histology
Pancreata were fixed overnight in 4% formaldehyde and embedded in
paraffin. Sections were rehydrated and heated for 20 min in Target Retrieval
Solution (pH 6.1, Dako). After blocking with 20% normal goat serum (Dako)
in PBS, slides were incubated with 1/1,000 anti-hGH monoclonal antibody
(ab15317, Abcam) in Antibody Diluent (Dako). For double immunofluorescent
labeling, 1/50,000 rabbit anti-serotonin (Immunostar, #20080) or 1/2,000 poly-
clonal anti-GLUT2 (07-1402, Millipore) was combined with 1/10,000 diluted
guinea pig anti-insulin antibody (a gift of Dr. Van Schravendijk, VUB, Brussels)
and detected with anti-rabbit Cy3 and anti-guinea pig FITC, respectively (both
from Jackson ImmunoResearch Laboratories). For MIP-GFP and RIP-Cre
mice, frozen sections were stained with 1/10,000 rabbit anti-serotonin or 1/
200 mouse anti-hGH (blocking with Mouse on Mouse [M.O.M.] Basic Kit
from Vector Laboratories) and costained with 1/2,000 guinea pig anti-insulin
in sections from RIP-Cre mice. For MIP-GFP, direct fluorescence for GFP
was used to detect b cells.
Glucose and Insulin Tolerance Tests
Overnight (glucose tolerance test [GTT]) or 6 hr fasted (insulin tolerance test
[ITT]) mice were injected i.p. with 2.5 mg/g BW D-glucose or 0.75 mU/g BW
human insulin, respectively, and glycemia wasmeasured by tail-blood analysisCell Musing a Contour glucosemeter (Bayer). For GTT, tail blood was collected at the
indicated time points, and plasma was analyzed.
Islet Serotonin and GABA Content
A total of 80 islets were homogenized by 3min sonication in a buffer containing
0.01 mol/l HCl, 1 mmol/l EDTA, and 4 mmol/l sodium metabisulfite. After
centrifugation (20,0003 g) for 15 min at 4C and addition of 0.1% (w/v) ascor-
bic acid (Acros), lysates were stored at 80C. Serotonin and GABA concen-
trations were determined via high-performance liquid chromatography (HPLC)
(see Supplemental Experimental Procedures).
Islet hGH Content and Release
Freshly isolated islets were incubated in batches of 100 at 37C. Incubation
was in HEPES Krebs buffer (20 mmol/l HEPES [pH 7.4], 119 mmol/l NaCl,
4.75 mmol/l KCl, 2.5 mmol/l CaCl2, 1.2 mmol/l MgSO4, 1.2 mmol/l KH2PO4,
5 mmol/l NaHCO3, 0.5% [w/v] BSA) containing 20 mmol/l glucose. After
1 hr, half of the medium was removed for measurement of hGH release. For
the content, Triton X-100 (final concentration: 0.5%) was added to the other
half of the medium with the islets. Islets were sonicated for 3 min, and lysates
were stored at 20C. To measure concentrations, an hGH ELISA was used
(Invitrogen).
Islet Insulin Content and Release
For insulin secretion measurements, size-matched islets (n = 5 per tube) were
placed in glass tubes containing HEPES Krebs solution containing 0.5% BSA
supplemented with glucose 5 mM (G5), 20 mM (G20), or G20 with 250 mM
IBMX. Supernatant was collected after 1 hr incubation at 37C. The islets
were sonicated for 3 min after adding acid ethanol (final concentration: 75%
EtOH, 0.1 N HCl, 1% Triton). Samples were stored at 20C, and the ELISA
kit used for insulin determination was from Crystal Chem.etabolism 20, 979–990, December 2, 2014 ª2014 Elsevier Inc. 987
Figure 6. Model of hGH-Induced Pheno-
typic Changes in Pdx1-CreLate b Cells
Pdx1-promoter-driven expression of the hGH
minigene causes biosynthesis and secretion of
hGH, which exerts autocrine or paracrine effects
after binding to PRLR on b cells. This causes
STAT5 phosphorylation and pregnancy-like
phenotypic changes, such as enhanced b cell
mass and serotonin (5-HT) production. In addition,
expression of the hGH minigene causes preg-
nancy-unrelated changes, such as reduction of
GLUT2 expression and partial loss of glucose-
induced insulin release. Lower GLUT2-mediated
uptake and higher b cell mass protect against the
diabetogenic effect of the b cell toxin STZ.
Cell Metabolism
hGH-Induced Phenotypic Switch in Control IsletsTotal Pancreas Insulin Content
Pancreata were dissected, and acid-ethanol extracts were diluted 1/1,000
in PBS and analyzed for insulin using an insulin high-range ELISA (Mercodia).
Absolute insulin content per pancreas as well as relative content (corrected for
pancreas weight) were quantified.
b Cell Mass Quantification
Total pancreas from 24-week-old Pdx1-Crelate and littermate control mice
(four males per group) was processed, and six sections separated by
200 mm were stained for insulin as described above. The total surface area
of insulin-positive cells (in pixels) was quantified with Zeiss Axiovision software
(Micro Imaging). The relative insulin surface area per section (total insulin area
[pixels]/total pancreas area [pixels]) was multiplied by the pancreas weight
(mg) to obtain the b cell mass (mg).
Western Blot
Islets were isolated as described above and homogenized in lysis buffer (Cell
Signaling Technology) by sonication. Protein extracts were separated by SDS-
PAGE (10% [v/v] Bis/Tris gel; Life Technologies), blotted on a nitrocellulose
membrane, blocked in 4% (w/v) milk, and incubated with primary antibody
(anti-hGH, ab15317, 1/1,000; anti-GAPDH, 1/15,000; clone 6C5, both from
Abcam). The blot was subsequently incubated with peroxidase-conjugated
secondary antibody (Dako), and proteins were detected using the Western
Lightning ECL System (PerkinElmer). For hGH staining on islets from MIP-
GFP and RIP-Cre mice, a similar protocol was used with adjustments: 10 mg
of islet protein sample in 13 Laemmli sample buffer was resolved on 15%
SDS-PAGE and transferred to polyvinylidene difluoride membranes (EMD
Millipore).
Statistical Methods
When not differently stated in the legend or text, data are presented as mean ±
SEM, and significance is shown on graphs as *p < 0.05, **p < 0.01, or p < 0.001.
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